Mathilde Martinez
Utrecht University(NL)Dutch Cancer Society(NL)The Netherlands Cancer Institute(NL)Oncode Institute(NL)Clinique Pasteur(FR)Institute for Social Security and Services for State Workers(MX)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Cancer Immunotherapy and Biomarkers, Renal cell carcinoma treatment, Bladder and Urothelial Cancer Treatments, Breast Cancer Treatment Studies
Most-Cited Works
- → Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study(2004)24 cited
- → Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial(2024)24 cited
- → A pharmacogically guided phase I study of carboplatin in combination with methotrexate and vinblastine in advanced urothelial cancer(1995)17 cited
- → Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II study (FIRGEMAX)(2020)17 cited
- → Efficacy and safety results from neopembrov study, a randomized phase II trial of neoadjuvant chemotherapy (CT) with or without pembrolizumab (P) followed by interval debulking surgery and standard systemic therapy ± P for advanced high-grade serous carcinoma (HGSC): A GINECO study.(2021)12 cited